Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Crinetics Pharmaceuticals Inc buy Oppenheimer Holdings Inc.

Start price
€35.20
18.03.24 / 50%
Target price
€49.66
18.03.25
Performance (%)
9.66%
Price
€39.60
25.04.24
Summary
This prediction is currently active. The BUY prediction by Oppenheimer_Holdings shows slight gains of 9.66%. This prediction currently runs until 18.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Crinetics Pharmaceuticals Inc -1.980% -1.980%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Oppenheimer_Holdings for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 9.66%
Target price 49.658
Change
Ends at 18.03.25

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $54.00 price target on the stock, up previously from $48.00.
Ratings data for CRNX provided by MarketBeat

Stopped prediction by Oppenheimer_Holdings for Crinetics Pharmaceuticals Inc

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€42.20
20.03.24
€50.64
20.03.25
-6.16%
25.04.24

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€38.00
29.02.24
€44.35
28.02.25
4.21%
25.04.24

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€25.00
11.09.23
€42.75
11.09.24
58.40%
25.04.24

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€16.10
30.08.23
-
30.08.24
145.96%
25.04.24